Navigation Links
Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process

IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, announced that Solazyme, Inc., a renewable oil production company and leading algal synthetic biology company, is testing sugars, produced through BlueFire's patented process, for compatibility with its renewable oil process to produce the oil cost effectively and at scale.

(Logo: )

"Our technologies are a great fit for each other," stated Arnold Klann, CEO of BlueFire Ethanol Fuels, Inc. "Our patented acid hydrolysis process allows BlueFire Ethanol to utilize a variety of non-food feedstocks to produce sugars that can be used to make a variety of different types of fuels and chemicals. Supplying these low cost sugars to Solazyme's technology provides them with the option of creating a variety of oils for the renewable energy industry and beyond."

BlueFire Ethanol is currently focused on developing its first ethanol biorefinery in Lancaster, California. The Lancaster facility will use post-sorted cellulosic wastes diverted from landfills in Southern California to produce 3.9 million gallons of fuel-grade ethanol per year. The company was also awarded $40 million from the U.S. Department of Energy for construction of a second plant in Southern California, and has received the first installment of funding from the DOE for the development of the BlueFire Mecca, LLC plant in Southern California.

About Solazyme:

Solazyme, Inc. is a renewable oil production company and the leader in algal synthetic biology. Solazyme's unique microbial conversion technology process allows algae to produce oil in standard industrial facilities quickly, efficiently and at large scale. These oils are tailored not only for advanced biofuel production, but also as replacements for fossil petroleum and plant oils in a diverse range of products running from green household cleaning supplies to cosmetics and foods. The company was founded in 2003 and has its headquarters in South San Francisco, California. For more information, please visit

About BlueFire Ethanol Fuels

BlueFire Ethanol Fuels, Inc. was established to deploy a commercially ready, patented and proven Concentrated Acid Hydrolysis Technology Process for the profitable conversion of cellulosic ("Green Waste") waste materials to ethanol, a viable alternative to gasoline. BlueFire is the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues.

BlueFire is one of four ethanol companies awarded funding from the U.S. Department of Energy to construct ethanol production facilities. Unlike remote corn ethanol production plants, BlueFire's biorefineries will be located in markets with the highest demand for ethanol. This dramatically reduces delivery costs and increases biofuels supply, while providing a unique waste processing technology that helps cities better manage the problem of overflowing landfills. For more information, visit

Forward-Looking Statements

Statements about BlueFire Ethanol, Inc.'s expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. BlueFire's actual results could differ materially from expected results. BlueFire undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; BlueFire will appropriately inform the public.

SOURCE BlueFire Ethanol Fuels, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Solazyme Announces New Senior Vice President of Business Development
2. Solazyme Selected for National Institute of Standards and Technology Award
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. ElutraSep Inc. Announces the Launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia Testing
5. Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
6. University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
7. First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide
8. H1N1 Influenza "Swine Flu" Peptide Vaccine Now Available For Testing Worldwide
9. SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing
10. Microtest Labs Expands Clean Room, Contamination Testing Services
11. EnWave Announces Collaboration and Initial Testing Results with Danisco AS
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
Breaking Biology News(10 mins):